Literature DB >> 1554414

Multiple molecular alterations in mouse lung tumors.

F C Re1, G Manenti, M G Borrello, M P Colombo, J H Fisher, M A Pierotti, G Della Porta, T A Dragani.   

Abstract

Twenty-five mouse lung tumors induced by a single urethan treatment in female A/J, BALB/c, and (A/J x C3H/He)F1 (AC3) mice were analyzed for the presence of mutations at codon 61 of the Ki-ras gene and for the expression of the surfactant protein A (SP-A), retinoblastoma (Rb), growth arrest-specific-3 (gas-3), p53, c-myc, and thymidylate synthase (TS) genes. Ki-ras codon 61 mutations were detected in 22 of 25 tumor samples without differences among strains. In comparison with normal lungs, all the tumors showed increased SP-A mRNA levels, indicating their derivation from alveolar type II pneumocytes or Clara cells. Rb and gas-3 transcripts were instead found in all tumors at about tenfold and about 20-fold reduced levels, respectively. No apparent structural alterations or loss of heterozygosity at the Rb locus was detected in any tumors. The p53 mRNA was observed without variation in quantity or size in lung tumors and normal tissue. A threefold to fivefold c-myc overexpression was observed, without amplification of the gene. TS expression was only slightly increased, indicating no great differences in cell proliferation between lung tumors and normal tissue. Our data suggest that the pathogenesis of urethan-induced lung tumors in mice involves specific and recurrent molecular alterations (Ki-ras mutations, decrease of Rb and gas-3 expression, and increase of c-myc expression) that could represent different steps in lung carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1554414     DOI: 10.1002/mc.2940050211

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  8 in total

1.  Peripheral myelin protein 22 is in complex with alpha6beta4 integrin, and its absence alters the Schwann cell basal lamina.

Authors:  Stephanie A Amici; William A Dunn; Andrew J Murphy; Niels C Adams; Nicholas W Gale; David M Valenzuela; George D Yancopoulos; Lucia Notterpek
Journal:  J Neurosci       Date:  2006-01-25       Impact factor: 6.167

Review 2.  Review of the GAS3 Family of Proteins and their Relevance to Cancer.

Authors:  Negin Ashki; Lynn Gordon; Madhuri Wadehra
Journal:  Crit Rev Oncog       Date:  2015

3.  Morphological changes and proliferative activity of alveolar epithelium in mouse lungs treated with urethan.

Authors:  Y Monobe; T Manabe
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

4.  Differential gene expression in chemically induced mouse lung adenomas.

Authors:  Ruisheng Yao; Yian Wang; Ronald A Lubet; Ming You
Journal:  Neoplasia       Date:  2003 Jan-Feb       Impact factor: 5.715

5.  Complex genetic control of lung tumorigenesis in resistant mice strains.

Authors:  Alice Dassano; Giulia Pintarelli; Chiara E Cotroneo; Angela Pettinicchio; Elena Forcati; Loris De Cecco; Andrea Borrego; Francesca Colombo; Tommaso A Dragani; Giacomo Manenti
Journal:  Cancer Sci       Date:  2017-10-06       Impact factor: 6.716

6.  Inhibition of protein PMP22 enhances etoposide-induced cell apoptosis by p53 signaling pathway in Gastric Cancer.

Authors:  Jingjing Hou; Lin Wang; Jiabao Zhao; Huiqin Zhuo; Jia Cheng; Xin Chen; Wei Zheng; Zhijun Hong; Jianchun Cai
Journal:  Int J Biol Sci       Date:  2021-07-25       Impact factor: 6.580

7.  Mouse pulmonary adenoma susceptibility 1 locus is an expression QTL modulating Kras-4A.

Authors:  Alice Dassano; Francesca Colombo; Gaia Trincucci; Elisa Frullanti; Antonella Galvan; Angela Pettinicchio; Loris De Cecco; Andrea Borrego; Olga Célia Martinez Ibañez; Tommaso A Dragani; Giacomo Manenti
Journal:  PLoS Genet       Date:  2014-04-17       Impact factor: 5.917

8.  Ablating all three retinoblastoma family members in mouse lung leads to neuroendocrine tumor formation.

Authors:  Sara Lázaro; Miriam Pérez-Crespo; Ana Belén Enguita; Pilar Hernández; Jesús Martínez-Palacio; Marta Oteo; Julien Sage; Jesús M Paramio; Mirentxu Santos
Journal:  Oncotarget       Date:  2017-01-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.